Press

Oct24th2018

First Cannabis Company to Bring Innovative Pod-based Vaporizing Technology to Canada & Europe

Target Group Inc. (OTCQB: CBDY) today announced an exclusive licensing, distribution and central processing agreement for Canada and Europe with Massachusetts-based CannaKorp Inc. (“CannaKorp”)...

Read More

Oct24th2018

Target Group Inc. Announces Upgrade to the OTCQB Venture Market

Target Group Inc. (“Target” or the “Company”) (OTC: CBDY) announced today its Common shares have been upgraded to a listing on the OTCQB...

Read More

Aug8th2018

Target Group Inc. Announces the Completion of Acquisition of Visava Inc.

Effective August 2, 2018, Target Group Inc. (CBDY) completed the acquisition of all of the issued and outstanding common stock of Visava Inc. (“Visava”)....

Read More

Jul10th2018

Target Group Inc. (CBDY) Announces the Acquisition of Visava Inc.

Visava Inc., 100% owner of Canary RX Inc. has been acquired by Target Group Inc. (CBDY) Effective June 27, 2018, Target Group Inc. ( CBDY )...

Read More

Jul7th2018

Canary Receives ‘Confirmation of Readiness’ from Health Canada

Late stage ACMPR Applicant, Canary, receives ‘Letter of Readiness’ from Health Canada Canary Rx Inc. (“Canary”) is pleased to announce that it has...

Read More

Jun13th2018

Ample Organics, Seed to Sale Experts

Canary’s Intuitive, Systematic, Record Keeping Platform One of the key requirements of the Access to Cannabis for Medical Purposes Regulations (ACMPR) is that...

Read More

Mar26th2018

Canary Progresses to Active Review

Health Canada Notifies Canary of Active Review Status Canary Rx Inc. (“Canary”) is pleased to announce that its application to become a licensed...

Read More

Dec16th2017

Canary has Officially Rebranded

Canary is Dropping the RX, and Adopting a Sleek New Look to Prepare for Licensing Canary is delighted to officially unveil our company-wide...

Read More